Hypha Discovery is a microbial technology company helping partners in pharmaceutical and agrochemical R&D succeed through the discovery and production of microbial and mammalian metabolites. We are experts in the scalable production of DMPK metabolites and generation of polar analogues, and are also a leading provider of unique natural product screening libraries and associated services.
NEWS & EVENTS
Come and meet us at the following events:
46th DMDG Open Meeting 2017, 20th-22nd September 2017, Robinson College, Cambridge,UK
21st North American ISSX Meeting, 24th-28th September 2017, Providence, Rhode Island, USA
Come and see us at booth 310 or at our poster on “Human metabolites of bosentan produced by enzymes in Hypha’s PolyCYPsTM cytochrome P450 kit”. Download a copy here.
Bio Japan 2017, 11th-13th October, Pacifico Yokohama, Japan
Hypha will join the Mayor’s International Business Programme Trade Mission to Bio Japan.
Request a meeting or drop by the UK Pavilion
The Korean Society of Non-Clinical Study Jeju Workshop, 19th-20th October, Phoenix Jeju Resort, Seogwipo, Jeju-island, Korea
2017년 10월 19일(목) 13:00 ~ 10월 20일(금) 15:00
제주 휘닉스 아일랜드
제주에서 만나뵙기를 기대하겠습니다 !
Download a copy of our brochure on drug metabolites and C-H activated derivatives
Our new brochure on drug metabolites and C-H activated derivatives is now available. Inside we feature interesting case studies and client projects, including the following topics:
- Phase l CYP and non-CYP metabolites
- Phase ll conjugated metabolites
- Isotopically labelled metabolites
- Lead diversification and late stage functionalization
- Polar / C-H activated derivatives
In our latest newsletter we look at off-target activity of some drug metabolites, exemplified with a case study looking at metabolism of valsartan.